Topoisomerase I poisons-induced autophagy: Cytoprotective, Cytotoxic or Non-protective-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Topoisomerase I poisons-induced autophagy: Cytoprotective, Cytotoxic or Non-protective

Published:2022-12-25 Issue:1 Volume:2 Page:1-16
ISSN:2769-4127
Container-title:Autophagy Reports
language:en
Short-container-title:Autophagy Reports

Author:

Elshazly Ahmed M.¹²,Wright Polina A.¹,Xu Jingwen³,Gewirtz David A.¹^ORCID

Affiliation:

1. Department of Pharmacology and Toxicology, Virginia Commonwealth University, Massey Cancer Center, 401 College St., Richmond, VA 23298, USA

2. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh 33516, Egypt

3. School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China

Funder

National Institutes of Health

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/27694127.2022.2155904

Reference58 articles.

1. The Roles of Autophagy and Senescence in the Tumor Cell Response to Radiation

2. Xu J, Gewirtz DA. Is Autophagy Always a Barrier to Cisplatin Therapy? Biomolecules. 2022;12(3).

3. Therapeutic Potential for Targeting Autophagy in ER+ Breast Cancer

4. Self-Eating for Muscle Fitness: Autophagy in the Control of Energy Metabolism

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rationally designed catalytic nanoplatform for enhanced chemoimmunotherapy via deploying endogenous plus exogenous copper and remodeling tumor microenvironment;Journal of Nanobiotechnology;2024-09-09

2. Is Autophagy Targeting a Valid Adjuvant Strategy in Conjunction with Tyrosine Kinase Inhibitors?;Cancers;2024-08-28

3. Selagibenzophenone B and Its Derivatives: SelB-1, a Dual Topoisomerase I/II Inhibitor Identified through In Vitro and In Silico Analyses;ACS Bio & Med Chem Au;2024-07-26

4. The Cytoprotective and Cytotoxic Functions of Autophagy in Response to mTOR Inhibitors;Frontiers in Bioscience-Landmark;2024-06-24

5. Autophagy and senescence facilitate the development of antiestrogen resistance in ER positive breast cancer;Frontiers in Endocrinology;2024-03-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3